NZ245612A - Substituted thiazolidine derivatives; pharmaceutical compositions and preparatory processes - Google Patents

Substituted thiazolidine derivatives; pharmaceutical compositions and preparatory processes

Info

Publication number
NZ245612A
NZ245612A NZ245612A NZ24561292A NZ245612A NZ 245612 A NZ245612 A NZ 245612A NZ 245612 A NZ245612 A NZ 245612A NZ 24561292 A NZ24561292 A NZ 24561292A NZ 245612 A NZ245612 A NZ 245612A
Authority
NZ
New Zealand
Prior art keywords
compound
formula
group
thiazolidine
dione
Prior art date
Application number
NZ245612A
Other languages
English (en)
Inventor
Takao Yoshioka
Takahide Nishi
Tsutomu Kanai
Yuichi Aizawa
Kunio Wada
Takashi Fujita
Hiroyoshi Horikoshi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NZ245612A publication Critical patent/NZ245612A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NZ245612A 1991-12-26 1992-12-23 Substituted thiazolidine derivatives; pharmaceutical compositions and preparatory processes NZ245612A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34457191 1991-12-26

Publications (1)

Publication Number Publication Date
NZ245612A true NZ245612A (en) 1994-06-27

Family

ID=18370304

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ245612A NZ245612A (en) 1991-12-26 1992-12-23 Substituted thiazolidine derivatives; pharmaceutical compositions and preparatory processes

Country Status (21)

Country Link
EP (1) EP0549365B1 (enExample)
JP (1) JP2833949B2 (enExample)
CN (1) CN1032751C (enExample)
AT (1) ATE126221T1 (enExample)
AU (1) AU654223B2 (enExample)
CA (1) CA2086277A1 (enExample)
CZ (1) CZ389792A3 (enExample)
DE (1) DE69204041T2 (enExample)
DK (1) DK0549365T3 (enExample)
ES (1) ES2078671T3 (enExample)
FI (1) FI925849A7 (enExample)
GR (1) GR3017632T3 (enExample)
HK (1) HK196095A (enExample)
HU (1) HU215450B (enExample)
IL (1) IL104238A (enExample)
MX (1) MX9207595A (enExample)
NO (1) NO302471B1 (enExample)
NZ (1) NZ245612A (enExample)
RU (1) RU2095354C1 (enExample)
TW (1) TW211007B (enExample)
ZA (1) ZA9210021B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO302519B1 (no) * 1991-12-26 1998-03-16 Sankyo Co Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat
CA2146701A1 (en) * 1994-04-11 1995-10-12 Takashi Fujita Heterocyclic compounds having anti-diabetic activity, their preparation and their use
EP0783888A1 (en) 1995-12-26 1997-07-16 Sankyo Company Limited Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis
US6331633B1 (en) * 1998-05-08 2001-12-18 Calyx Therapeutics Inc. Heterocyclic analogs of diphenylethylene compounds
DE19828113A1 (de) * 1998-06-24 2000-01-05 Probiodrug Ges Fuer Arzneim Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
DE19828114A1 (de) * 1998-06-24 2000-01-27 Probiodrug Ges Fuer Arzneim Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
DE19926233C1 (de) * 1999-06-10 2000-10-19 Probiodrug Ges Fuer Arzneim Verfahren zur Herstellung von Thiazolidin
US6620830B2 (en) 2000-04-21 2003-09-16 Pfizer, Inc. Thyroid receptor ligands
DE60115132T2 (de) * 2000-04-21 2006-07-06 Pfizer Products Inc., Groton Thyroid-Rezeptorliganden
US6680387B2 (en) 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
CA2402123A1 (en) * 2000-04-24 2001-11-01 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
JP2003040877A (ja) * 2001-07-24 2003-02-13 Sumika Fine Chemicals Co Ltd ５−［６−（２−フルオロベンジルオキシ）−２−ナフチル］メチル−２，４−チアゾリジンジオンの製造方法及びその精製方法
NZ571870A (en) 2006-03-16 2011-07-29 Metabolic Solutions Dev Co Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids
AU2007227581B2 (en) 2006-03-16 2012-11-08 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
WO2009038681A1 (en) * 2007-09-14 2009-03-26 Metabolic Solutions Development Company Thiazolidinedione analogues for the treatment of hypertension
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
NZ600390A (en) 2009-12-15 2013-08-30 Metabolic Solutions Dev Co Llc Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases
MX2012012092A (es) * 2010-04-19 2012-12-17 Metabolic Solutions Dev Co Llc Sintesis novedosa para compuestos de tiazolidinadiona.
AU2011242844A1 (en) * 2010-04-21 2012-11-01 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues
NZ606574A (en) 2010-08-10 2015-02-27 Metabolic Solutions Dev Co Llc Novel synthesis for thiazolidinedione compounds
CN115433144B (zh) * 2022-10-09 2023-09-19 燃点(南京)生物医药科技有限公司 一种脂肪酸酯类化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US5143930A (en) * 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
NO302519B1 (no) * 1991-12-26 1998-03-16 Sankyo Co Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat

Also Published As

Publication number Publication date
RU2095354C1 (ru) 1997-11-10
DE69204041D1 (de) 1995-09-14
ATE126221T1 (de) 1995-08-15
FI925849A7 (fi) 1993-06-27
CN1032751C (zh) 1996-09-11
AU654223B2 (en) 1994-10-27
FI925849A0 (fi) 1992-12-23
MX9207595A (es) 1994-06-30
AU3043192A (en) 1993-07-01
GR3017632T3 (en) 1996-01-31
IL104238A (en) 1996-10-31
HU9204130D0 (en) 1993-04-28
ZA9210021B (en) 1993-07-02
CA2086277A1 (en) 1993-06-27
EP0549365A1 (en) 1993-06-30
NO302471B1 (no) 1998-03-09
JP2833949B2 (ja) 1998-12-09
CN1074680A (zh) 1993-07-28
DK0549365T3 (da) 1995-12-18
DE69204041T2 (de) 1996-03-28
HU215450B (hu) 1999-04-28
EP0549365B1 (en) 1995-08-09
NO924964L (no) 1993-06-28
HK196095A (en) 1996-01-05
ES2078671T3 (es) 1995-12-16
CZ389792A3 (en) 1994-01-19
JPH05239041A (ja) 1993-09-17
NO924964D0 (no) 1992-12-22
TW211007B (enExample) 1993-08-11
HUT67788A (en) 1995-04-28

Similar Documents

Publication Publication Date Title
NZ245612A (en) Substituted thiazolidine derivatives; pharmaceutical compositions and preparatory processes
US5143930A (en) Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
RU2095344C1 (ru) Производные 1-амино-2-замещенного фенилэтанола, способ их получения (варианты)
KR960005168B1 (ko) 티아졸리디논 유도체, 그 제조방법 및 용도
US5338855A (en) Thiazolidine compounds containing a quinone group, their preparation and their therapeutic uses
DE60020381T2 (de) Substituierte benzylthiazolidin-2,4-dion-derivate
EP0454501B1 (en) Benzylidenethiazolidine derivatives, their preparation and their use for the inhibition of lipid peroxides
IL106839A (en) Oxazolidine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
AU2004259000A1 (en) Design and synthesis of optimized ligands for PPAR
US7521465B2 (en) Diphenyl ether derivatives
US5308856A (en) Thiazolidine-2,4-dione derivatives, salts and preparation processes thereof
HK1007050B (en) Thiazolidine compounds containing a quinone group, their preparation and their therapeutic uses
HK1005451B (en) Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
JPWO1996020186A1 (ja) カルボン酸誘導体、その製造方法及びそれを含有する医薬組成物